MESOTELIOMA
- Inicio
- MESOTELIOMA
- PROMISE-Meso
- BEAT-Meso
PROMISE-Meso
Multicentre randomised phase III trial comparing pembrolizumab versus standard chemotherapy for advanced pre-treated malignant pleural mesothelioma.
Promotor: ETOP
Coordinador en España: Dr. Ernest Nadal
Centros participantes
- Institut Català d’Oncologia-Hospitalet
- Hospital Clínico Universitario de Valladolid
- Hospital Teresa Herrera, A Coruña
BEAT-Meso
A multicentre randomised phase III trial comparing atezolizumab plus bevacizumab and standard chemotherapy versus bevacizumab and standard chemotherapy as first-line treatment in advanced malignant pleural mesothelioma
Promotor: ETOP
Coordinador en España: Dr. Enriqueta Felip and Dr. Sanjay Popat
Centros participantes
- Hospital Parc Taulí Sabadell
- Hospital Univ. Virgen del Rocio
- Hospital Univ. General de Alicante
- Complejo Hospitalario de Vigo
- Hospital Univ. Puerta de Hierro
- Hospital Univ. Vall d’Hebron
- ICO Hospitalet
